ROC curve analysis US Medical PG Practice Questions and MCQs
Practice US Medical PG questions for ROC curve analysis. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
ROC curve analysis US Medical PG Question 1: A scientist in Chicago is studying a new blood test to detect Ab to EBV with increased sensitivity and specificity. So far, her best attempt at creating such an exam reached 82% sensitivity and 88% specificity. She is hoping to increase these numbers by at least 2 percent for each value. After several years of work, she believes that she has actually managed to reach a sensitivity and specificity much greater than what she had originally hoped for. She travels to China to begin testing her newest blood test. She finds 2,000 patients who are willing to participate in her study. Of the 2,000 patients, 1,200 of them are known to be infected with EBV. The scientist tests these 1,200 patients' blood and finds that only 120 of them tested negative with her new exam. Of the patients who are known to be EBV-free, only 20 of them tested positive. Given these results, which of the following correlates with the exam's specificity?
- A. 82%
- B. 90%
- C. 84%
- D. 86%
- E. 98% (Correct Answer)
ROC curve analysis Explanation: ***98%***
- **Specificity** measures the proportion of **true negatives** among all actual negatives.
- In this case, 800 patients are known to be EBV-free (actual negatives), and 20 of them tested positive (false positives). This means 800 - 20 = 780 tested negative (true negatives). Specificity = (780 / 800) * 100% = **98%**.
*82%*
- This value represents the *original sensitivity* before the scientist’s new attempts to improve the test.
- It does not reflect the *newly calculated specificity* based on the provided data.
*90%*
- This value represents the *newly calculated sensitivity* of the test, not the specificity.
- Out of 1200 EBV-infected patients, 120 tested negative (false negatives), meaning 1080 tested positive (true positives). Sensitivity = (1080 / 1200) * 100% = 90%.
*84%*
- This percentage is not directly derived from the information given for either sensitivity or specificity after the new test results.
- It does not correspond to any of the calculated values for the new test's performance.
*86%*
- This percentage is not directly derived from the information given for either sensitivity or specificity after the new test results.
- It does not correspond to any of the calculated values for the new test's performance.
ROC curve analysis US Medical PG Question 2: A group of neurologists develop a new blood test for Alzheimer's. They are optimistic about the test, as they have found that for any given patient, the test repeatedly produces very similar results. However, they find that the new test results are not necessarily consistent with the gold standard of diagnosis. How would this new test most accurately be described?
- A. Valid and reliable
- B. Reliable (Correct Answer)
- C. Valid
- D. Biased
- E. Neither valid nor reliable
ROC curve analysis Explanation: ***Reliable***
- The test produces **similar results repeatedly** upon repeated measures, indicating high **reliability** or **precision**.
- Reliability refers to the **consistency** of a measure, even if it is not accurate.
*Valid and reliable*
- While the test is **reliable**, it is explicitly stated that the results are **not consistent with the gold standard**, meaning it lacks **validity**.
- A test must be both **consistent** (reliable) and **accurate** (valid) to be described as valid and reliable.
*Valid*
- **Validity** refers to the **accuracy** of a test, or how well it measures what it is supposed to measure.
- The test is explicitly stated to **not be consistent with the gold standard**, indicating a lack of agreement with the true measure of Alzheimer's.
*Biased*
- **Bias** refers to a **systematic error** in measurement that can lead to consistently high or low results compared to the true value.
- While the test might be biased due to its lack of consistency with the gold standard, "biased" is not the most accurate single descriptor of its measurement properties given the information provided.
*Neither valid nor reliable*
- The test is described as producing **very similar results repeatedly**, which directly indicates it has **high reliability**.
- Therefore, stating it is neither valid nor reliable is incorrect, as it possesses reliability.
ROC curve analysis US Medical PG Question 3: A home drug screening test kit is currently being developed. The cut-off level is initially set at 4 mg/uL, which is associated with a sensitivity of 92% and a specificity of 97%. How might the sensitivity and specificity of the test change if the cut-off level is changed to 2 mg/uL?
- A. Sensitivity = 92%, specificity = 97%
- B. Sensitivity = 95%, specificity = 98%
- C. Sensitivity = 100%, specificity = 97%
- D. Sensitivity = 90%, specificity = 99%
- E. Sensitivity = 97%, specificity = 96% (Correct Answer)
ROC curve analysis Explanation: ***Sensitivity = 97%, specificity = 96%***
- Lowering the cut-off from 4 mg/uL to 2 mg/uL means that more individuals will be classified as **positive** (anyone with drug levels ≥2 mg/uL instead of ≥4 mg/uL). This change will **increase the sensitivity** (capturing more true positives, fewer false negatives) but **decrease the specificity** (more false positives among those without the condition).
- Therefore, sensitivity will increase (e.g., to 97%), and specificity will decrease (e.g., to 96%), reflecting the fundamental trade-off between these metrics.
*Sensitivity = 92%, specificity = 97%*
- This option reflects the **original values** at the 4 mg/uL cut-off and does not account for the change in the threshold.
- A change in the cut-off level will inherently alter the test's performance characteristics.
*Sensitivity = 95%, specificity = 98%*
- This option suggests an increase in **both sensitivity and specificity**, which is generally not possible by simply changing the cut-off level in the same direction.
- There is typically an **inverse relationship** between sensitivity and specificity when adjusting the cut-off threshold.
*Sensitivity = 100%, specificity = 97%*
- Reaching **100% sensitivity** while maintaining a high specificity is highly unlikely with a simple cut-off adjustment.
- While sensitivity would increase with a lower cut-off, achieving perfect sensitivity is unrealistic in clinical practice.
*Sensitivity = 90%, specificity = 99%*
- This option suggests a **decrease in sensitivity** and an **increase in specificity**.
- A lower cut-off would lead to more positive results, thus increasing sensitivity and reducing specificity, which contradicts the proposed values.
ROC curve analysis US Medical PG Question 4: A scientist in Boston is studying a new blood test to detect Ab to the parainfluenza virus with increased sensitivity and specificity. So far, her best attempt at creating such an exam reached 82% sensitivity and 88% specificity. She is hoping to increase these numbers by at least 2 percent for each value. After several years of work, she believes that she has actually managed to reach a sensitivity and specificity even greater than what she had originally hoped for. She travels to South America to begin testing her newest blood test. She finds 2,000 patients who are willing to participate in her study. Of the 2,000 patients, 1,200 of them are known to be infected with the parainfluenza virus. The scientist tests these 1,200 patients’ blood and finds that only 120 of them tested negative with her new test. Of the following options, which describes the sensitivity of the test?
- A. 82%
- B. 86%
- C. 98%
- D. 90% (Correct Answer)
- E. 84%
ROC curve analysis Explanation: ***90%***
- **Sensitivity** is calculated as the number of **true positives** divided by the total number of individuals with the disease (true positives + false negatives).
- In this scenario, there were 1200 infected patients (total diseased), and 120 of them tested negative (false negatives). Therefore, 1200 - 120 = 1080 patients tested positive (true positives). The sensitivity is 1080 / 1200 = 0.90, or **90%**.
*82%*
- This value was the **original sensitivity** of the test before the scientist improved it.
- The question states that the scientist believes she has achieved a sensitivity "even greater than what she had originally hoped for."
*86%*
- This value is not directly derivable from the given data for the new test's sensitivity.
- It might represent an intermediate calculation or an incorrect interpretation of the provided numbers.
*98%*
- This would imply only 24 false negatives out of 1200 true disease cases, which is not the case (120 false negatives).
- A sensitivity of 98% would be significantly higher than the calculated 90% and the initial stated values.
*84%*
- This value is not derived from the presented data regarding the new test's performance.
- It could be mistaken for an attempt to add 2% to the original 82% sensitivity, but the actual data from the new test should be used.
ROC curve analysis US Medical PG Question 5: A family doctor in a rural area is treating a patient for dyspepsia. The patient had chronic heartburn and abdominal pain for the last 2 months and peptic ulcer disease due to a suspected H. pylori infection. For reasons relating to affordability and accessibility, the doctor decides to perform a diagnostic test in the office that is less invasive and more convenient. Which of the following is the most likely test used?
- A. Steiner's stain
- B. Culture of organisms from gastric specimen
- C. Stool antigen test (Correct Answer)
- D. Detection of the breakdown products of urea in biopsy
- E. Serology (ELISA testing)
ROC curve analysis Explanation: ***Stool antigen test***
- This **non-invasive** and **cost-effective** test detects *H. pylori* antigens in stool, making it suitable for a rural setting with limited resources.
- It is highly sensitive and specific, useful for both initial diagnosis and confirming eradication after treatment.
*Steiner's stain*
- **Steiner's stain** (Steiner silver stain) is primarily used for histological visualization of *Legionella* species, and **not for** *H. pylori* detection in routine clinical practice.
- It requires an **endoscopic biopsy**, making it more invasive and costly than the stool antigen test.
*Culture of organisms from gastric specimen*
- This method requires an **endoscopic biopsy** and specialized culture facilities, which may not be available in a rural doctor's office.
- It is more expensive and time-consuming, and primarily used when **antibiotic resistance** is suspected.
*Detection of the breakdown products of urea in biopsy*
- This refers to the **rapid urease test** (e.g., CLOtest), which is performed on a **gastric biopsy** obtained during endoscopy.
- While quick, it is an **invasive procedure** requiring endoscopy, which contradicts the patient's and doctor's preferences for a less invasive test.
*Serology (ELISA testing)*
- **Serology** detects antibodies to *H. pylori* but cannot differentiate between **active infection** and **past exposure**.
- Its utility in monitoring eradication is limited, and it's generally not recommended as the primary diagnostic test due to its inability to confirm active infection.
ROC curve analysis US Medical PG Question 6: An investigator is measuring the blood calcium level in a sample of female cross country runners and a control group of sedentary females. If she would like to compare the means of the two groups, which statistical test should she use?
- A. Chi-square test
- B. Linear regression
- C. t-test (Correct Answer)
- D. ANOVA (Analysis of Variance)
- E. F-test
ROC curve analysis Explanation: ***t-test***
- A **t-test** is appropriate for comparing the means of two independent groups, such as the blood calcium levels between runners and sedentary females.
- It assesses whether the observed difference between the two sample means is statistically significant or occurred by chance.
*Chi-square test*
- The **chi-square test** is used to analyze categorical data to determine if there is a significant association between two variables.
- It is not suitable for comparing continuous variables like blood calcium levels.
*Linear regression*
- **Linear regression** is used to model the relationship between a dependent variable (outcome) and one or more independent variables (predictors).
- It aims to predict the value of a variable based on the value of another, rather than comparing means between groups.
*ANOVA (Analysis of Variance)*
- **ANOVA** is used to compare the means of **three or more independent groups**.
- Since there are only two groups being compared in this scenario, a t-test is more specific and appropriate.
*F-test*
- The **F-test** is primarily used to compare the variances of two populations or to assess the overall significance of a regression model.
- While it is the basis for ANOVA, it is not the direct test for comparing the means of two groups.
ROC curve analysis US Medical PG Question 7: You conduct a medical research study to determine the screening efficacy of a novel serum marker for colon cancer. The study is divided into 2 subsets. In the first, there are 500 patients with colon cancer, of which 450 are found positive for the novel serum marker. In the second arm, there are 500 patients who do not have colon cancer, and only 10 are found positive for the novel serum marker. What is the overall sensitivity of this novel test?
- A. 450 / (450 + 10)
- B. 490 / (10 + 490)
- C. 490 / (50 + 490)
- D. 450 / (450 + 50) (Correct Answer)
- E. 490 / (450 + 490)
ROC curve analysis Explanation: ***450 / (450 + 50)***
- **Sensitivity** is defined as the proportion of actual positive cases that are correctly identified by the test.
- In this study, there are **500 patients with colon cancer** (actual positives), and **450 of them tested positive** for the marker, while **50 tested negative** (500 - 450 = 50). Therefore, sensitivity = 450 / (450 + 50) = 450/500 = 0.9 or 90%.
*450 / (450 + 10)*
- This formula represents **Positive Predictive Value (PPV)**, which is the probability that a person with a positive test result actually has the disease.
- It incorrectly uses the total number of **test positives** in the denominator (450 true positives + 10 false positives) instead of the total number of diseased individuals, which is needed for sensitivity.
*490 / (10 + 490)*
- This is actually the correct formula for **specificity**, not sensitivity.
- Specificity = TN / (FP + TN) = 490 / (10 + 490) = 490/500 = 0.98 or 98%, which measures the proportion of actual negative cases correctly identified.
- The question asks for sensitivity, not specificity.
*490 / (50 + 490)*
- This formula incorrectly mixes **true negatives (490)** with **false negatives (50)** in an attempt to calculate specificity.
- The correct specificity formula should use false positives (10), not false negatives (50), in the denominator: 490 / (10 + 490).
*490 / (450 + 490)*
- This calculation incorrectly combines **true negatives (490)** and **true positives (450)** in the denominator, which does not correspond to any standard epidemiological measure.
- Neither sensitivity nor specificity uses both true positives and true negatives in the denominator.
ROC curve analysis US Medical PG Question 8: A 1-minute-old newborn is being examined by the pediatric nurse. The nurse auscultates the heart and determines that the heart rate is 89/min. The respirations are spontaneous and regular. The chest and abdomen are both pink while the tips of the fingers and toes are blue. When the newborn’s foot is slapped the face grimaces and he cries loud and strong. When the arms are extended by the nurse they flex back quickly. What is this patient’s Apgar score?
- A. 5
- B. 10
- C. 8 (Correct Answer)
- D. 6
- E. 9
ROC curve analysis Explanation: ***8***
- The Apgar score is calculated by assigning 0, 1, or 2 points to five criteria: **Appearance**, **Pulse**, **Grimace (reflex irritability)**, **Activity (muscle tone)**, and **Respiration**.
- This newborn scores 1 point for **Appearance** (pink body, blue extremities/acrocyanosis), 1 point for **Pulse** (89/min, which is below 100), 2 points for **Grimace** (cries loud and strong), 2 points for **Activity** (arms flex back quickly), and 2 points for **Respiration** (spontaneous and regular), totaling **8**.
*5*
- An Apgar score of 5 would indicate a more compromised state, with lower scores in multiple categories.
- This newborn demonstrates strong respiratory effort, vigorous cry, and active muscle tone, all inconsistent with a score of 5.
*10*
- A perfect score of 10 is rare and would require the newborn to have a **pink appearance throughout** (including extremities), a heart rate over 100 bpm, strong cry, active movement, and vigorous breathing.
- This newborn has two findings preventing a score of 10: **acrocyanosis** (blue extremities) and **heart rate of 89/min** (below 100).
*6*
- An Apgar score of 6 would imply more significant compromise, such as weak respiratory effort, minimal response to stimulation, or poor muscle tone.
- This newborn's strong cry, vigorous grimace response, and quick flexion indicate better performance than a score of 6.
*9*
- A score of 9 would mean only one parameter scores 1 point, with all others scoring 2 points.
- This newborn has **two parameters scoring 1 point**: **Appearance** (acrocyanosis) and **Pulse** (89/min, below 100), making the maximum possible score 8, not 9.
ROC curve analysis US Medical PG Question 9: During identification of severely decomposed remains, which of the following methods provides the most reliable means of positive identification?
- A. Birthmarks
- B. Facial features
- C. DNA analysis (Correct Answer)
- D. Personal effects
ROC curve analysis Explanation: ***DNA analysis***
- **DNA analysis** remains viable even in significantly degraded samples due to the stability and uniqueness of the genetic code, making it the most reliable method for positive identification of severely decomposed remains.
- It provides a definitive match that is **scientifically verifiable** and rarely subject to error when compared to ante-mortem samples or close relatives.
*Birthmarks*
- **Birthmarks** are soft tissue characteristics that often degrade or become indistinguishable in severely decomposed remains.
- Their presence and appearance can change over time or be obscured by **decomposition processes**, making them unreliable for identification in such cases.
*Facial features*
- **Facial features** rapidly deteriorate and distort after death, especially in severely decomposed remains, making visual recognition impossible.
- The soft tissues of the face are among the first to undergo **autolysis** and putrefaction.
*Personal effects*
- While **personal effects** (like jewelry or clothing) can provide circumstantial evidence, they do not offer positive identification of the individual's remains.
- These items can be easily lost, misplaced, or exchanged, and they do not directly identify the **biological individual**.
ROC curve analysis US Medical PG Question 10: You are tasked with analyzing the negative predictive value of an experimental serum marker for ovarian cancer. You choose to enroll 2,000 patients across multiple clinical sites, including both 1,000 patients with ovarian cancer and 1,000 age-matched controls. From the disease and control subgroups, 700 and 100 are found positive for this novel serum marker, respectively. Which of the following represents the NPV for this test?
- A. 700 / (700 + 300)
- B. 700 / (300 + 900)
- C. 700 / (700 + 100)
- D. 900 / (900 + 100)
- E. 900 / (900 + 300) (Correct Answer)
ROC curve analysis Explanation: ***900 / (900 + 300)***
- The **Negative Predictive Value (NPV)** is the probability that a person with a **negative test result** does not have the disease. It is calculated as **true negatives (TN)** divided by the sum of true negatives and **false negatives (FN)**, i.e., TN / (TN + FN).
- In this scenario: there are 1,000 ovarian cancer patients, and 700 tested positive, meaning **300 tested negative (false negatives)**. There are 1,000 controls, and 100 tested positive, meaning **900 tested negative (true negatives)**. Therefore, NPV = 900 / (900 + 300).
*700 / (700 + 300)*
- This calculation represents the sensitivity of the test, which is the proportion of true positives among all individuals with the disease (700 true positives / 1000 diseased individuals).
- It does not account for the true negatives or false positives, which are crucial for determining predictive values.
*700 / (300 + 900)*
- This formula mixes elements and does not correspond to a standard measure of test validity.
- The numerator (700) is the number of true positives, and the denominator incorrectly combines false negatives (300) and true negatives (900).
*700 / (700 + 100)*
- This calculation represents the **Positive Predictive Value (PPV)**, which is the probability that a person with a **positive test result** actually has the disease (700 true positives / (700 true positives + 100 false positives)).
- It does not assess the negative predictive power of the test.
*900 / (900 + 100)*
- This calculation represents the **specificity** of the test, which is the proportion of true negatives among all individuals without the disease (900 true negatives / 1000 controls).
- While this involves true negatives, it does not account for false negatives, which are essential for calculating NPV.
More ROC curve analysis US Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.